Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis

J Gen Intern Med. 2019 Jul;34(7):1119-1120. doi: 10.1007/s11606-019-04863-5.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / economics*
  • Cost Sharing / economics*
  • Cost Sharing / trends
  • Data Analysis*
  • Humans
  • Medicare Part B / economics*
  • Medicare Part B / trends
  • Medicare Part C / economics*
  • Medicare Part C / trends
  • United States

Substances

  • Antineoplastic Agents